MINERALYS THERAPEUTICS INC (MLYS) Institutional Ownership Changes & 13F Activity
MINERALYS THERAPEUTICS INC (MLYS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Deerfield Management Company, L.P., Wellington Management Group Llp, Suvretta Capital Management, Llc, Ghisallo Capital Management Llc, and Invesco Ltd..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +5,596 | +21.2% | 32,007 | $863.55K | Q2 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Buy | +116 | +331.4% | 151 | $4.07K | Q2 2026 | Sep 04, 2026 |
| Citadel Advisors Llc | Sell | -132,443 | -22.1% | 467,598 | $12.62M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Buy | +5,955 | +9.7% | 67,221 | $1.81M | Q2 2026 | Aug 24, 2026 |
| Nantahala Capital Management, Llc | Sell | -75,000 | -8.4% | 820,481 | $22.14M | Q2 2026 | Aug 19, 2026 |
| Coastal Bridge Advisors, Llc | Buy | +2,450 | — | 2,450 | $66.10K | Q2 2026 | Aug 17, 2026 |
| Capstone Investment Advisors, Llc | Sell | -1,301 | -13.4% | 8,374 | $225.93K | Q2 2026 | Aug 17, 2026 |
| Deerfield Management Company, L.P. | Buy | +3,958,000 | — | 3,958,000 | $106.79M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Sell | -2,552,352 | -76.0% | 806,716 | $21.77M | Q2 2026 | Aug 14, 2026 |
| Suvretta Capital Management, Llc | Sell | -1,364,776 | -88.7% | 173,886 | $4.69M | Q2 2026 | Aug 14, 2026 |
| Ghisallo Capital Management Llc | Buy | +1,125,000 | — | 1,125,000 | $30.35M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +1,091,180 | — | 1,091,180 | $29.44M | Q2 2026 | Aug 14, 2026 |
| Troluce Capital Advisors Llc | Buy | +1,073,753 | +163.9% | 1,728,753 | $46.64M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +1,050,000 | — | 1,050,000 | $28.33M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +919,163 | +68.4% | 2,262,476 | $61.04M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Sell | -854,326 | -85.3% | 147,402 | $3.98M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +696,498 | +132.6% | 1,221,758 | $32.96M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +673,633 | +85.8% | 1,458,676 | $39.36M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Sell | -664,952 | -72.7% | 249,776 | $6.74M | Q2 2026 | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Buy | +582,630 | +374.1% | 738,370 | $19.92M | Q2 2026 | Aug 14, 2026 |
| Armistice Capital, Llc | Buy | +560,000 | +47.6% | 1,736,000 | $46.84M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Sell | -534,463 | -60.2% | 352,729 | $9.52M | Q2 2026 | Aug 14, 2026 |
| Prosight Management, Lp | Buy | +449,795 | — | 449,795 | $12.14M | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Buy | +413,087 | — | 413,087 | $11.15M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +405,175 | +36.8% | 1,505,547 | $40.62M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +339,800 | +2154.7% | 355,570 | $9.59M | Q2 2026 | Aug 14, 2026 |
| 22Nw, Lp | Sell | -330,485 | -74.4% | 113,840 | $3.07M | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +309,689 | — | 309,689 | $8.36M | Q2 2026 | Aug 14, 2026 |
| Integral Health Asset Management, Llc | Sell | -300,000 | -40.0% | 450,000 | $12.14M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +281,104 | — | 281,104 | $7.58M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about MLYS activity
Which institutional owners are buying MLYS?
Institutional owners buying MLYS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in MLYS activity?
"Buy" means an investor increased their reported position in MLYS compared to the prior reporting period. This reflects growing exposure to MINERALYS THERAPEUTICS INC (MLYS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in MLYS increasing?
Institutional interest in MLYS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related MLYS Institutional Insights
- MLYS Overview
- MLYS 13F Institutional Holders
- MLYS Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MLYS Insider Trading & SEC Form 4 Activity
- MLYS Articles
- Top Institutional Investor Stock Rankings